ALS-L1023

· Hanmi Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ALS-L1023, covering 2016-10-11 to 2022-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH [Phase 2]